Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2024-09-04 00:00:00 ET · period of report 2024-08-30 · accession 0000875320-24-000211 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-09-04 | 2024-08-30 | VRTX | Bhatia Sangeeta N. | Dir | S - Sale+OE | $500.00 | -646 | 4,435 | -13% | -$323.0K |
| D | 2024-09-04 | 2024-08-30 | VRTX | Bhatia Sangeeta N. | Dir | M - OptEx | $152.74 | +646 | 5,081 | +15% | +$98.7K |
| D | 2024-09-04 | 2024-08-30 | VRTX | Bhatia Sangeeta N. | Dir | M - OptEx | $0.00 | -646 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-30 | S | D | 646 | $500.00 | 4,435 | D | — | — | |
| 2 | Common | Common Stock | 2024-08-30 | M | A | 646 | $152.74 | 5,081 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-08-30 | M | D | 646 | $0.00 | 0 | D | $152.74 · — to 2028-05-31 | 646 Common Stock | (F2) Fully vested. |